Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The function of SARS-CoV-2 spike protein is impaired by disulfide-bond disruption with mutation at cysteine-488 and by thiol-reactive N-acetyl-cysteine and glutathione
Mana Murae, Yoshimi Shimizu, Yuichiro Yamamoto, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 597, pp. 30-36
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Glutathione deficiency in the pathogenesis of SARS-CoV-2 infection and its effects upon the host immune response in severe COVID-19 disease
Carlos A. Labarrere, Ghassan S. Kassab
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 32
Molecular Mechanisms Related to Responses to Oxidative Stress and Antioxidative Therapies in COVID-19: A Systematic Review
Evangelia Eirini Tsermpini, Una Glamočlija, Fulden Ulucan‐Karnak, et al.
Antioxidants (2022) Vol. 11, Iss. 8, pp. 1609-1609
Open Access | Times Cited: 27
The Role of Glutathione in Prevention of COVID-19 Immunothrombosis: A Review
Ira Glassman, Nghia Le, Mercedeh Mirhosseini, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 3, pp. 59-59
Open Access | Times Cited: 16
Clinical Approach to Post-acute Sequelae After COVID-19 Infection and Vaccination
Nicolas Hulscher, Brian C. Procter, Cade Wynn, et al.
Cureus (2023)
Open Access | Times Cited: 14
Overcoming antibody-resistant SARS-CoV-2 variants with bispecific antibodies constructed using non-neutralizing antibodies
Tetsuya Inoue, Yuichiro Yamamoto, Kaoru Sato, et al.
iScience (2024) Vol. 27, Iss. 4, pp. 109363-109363
Open Access | Times Cited: 4
COVID-19 and One-Carbon Metabolism
Joanna Perła‐Kaján, Hieronim Jakubowski
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4181-4181
Open Access | Times Cited: 20
SARS-CoV-2 Main Protease Targets Host Selenoproteins and Glutathione Biosynthesis for Knockdown via Proteolysis, Potentially Disrupting the Thioredoxin and Glutaredoxin Redox Cycles
Ignacio A. Gallardo, Daniel A. Todd, Stella T. Lima, et al.
Antioxidants (2023) Vol. 12, Iss. 3, pp. 559-559
Open Access | Times Cited: 7
Exploring antiviral and anti-inflammatory effects of thiol drugs in COVID-19
Kritika Khanna, Wilfred W. Raymond, Jing Jin, et al.
AJP Lung Cellular and Molecular Physiology (2022) Vol. 323, Iss. 3, pp. L372-L389
Open Access | Times Cited: 12
Omicron Spike Protein is Vulnerable to Reduction
Zhong Yao, Betty Geng, Edyta Marcon, et al.
Journal of Molecular Biology (2023) Vol. 435, Iss. 13, pp. 168128-168128
Open Access | Times Cited: 6
Supporting Cells of the Human Olfactory Epithelium Co-Express the Lipid Scramblase TMEM16F and ACE2 and May Cause Smell Loss by SARS-CoV-2 Spike-Induced Syncytia
Andres Hernandez, Kevin Y. Gonzalez‐Velandia, Uday Rangaswamy, et al.
Cellular Physiology and Biochemistry (2022) Vol. 56, Iss. 3, pp. 254-269
Open Access | Times Cited: 11
The role of TLR7 agonists in modulating COVID-19 severity in subjects with loss-of-function TLR7 variants
Shaik Mohammad Naushad, Gowtham Mandadapu, M. Janaki Ramaiah, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
TXM peptides inhibit SARS-CoV-2 infection, syncytia formation, and lower inflammatory consequences
Tea Govednik, Duško Lainšček, Urška Kuhar, et al.
Antiviral Research (2024) Vol. 222, pp. 105806-105806
Open Access | Times Cited: 1
Developing of SARS-CoV-2 fusion protein expressed in E. coli Shuffle T7 for enhanced ELISA detection sensitivity – an integrated experimental and bioinformatic approach
Sohrab Sam, Hamideh Ofoghi, Behrokh Farahmand
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-16
Closed Access | Times Cited: 1
Inhibition Mechanism of SARS-CoV-2 Infection by a Cholesterol Derivative, Nat-20(S)-yne
Mana Murae, Shota Sakai, Non Miyata, et al.
Biological and Pharmaceutical Bulletin (2024) Vol. 47, Iss. 5, pp. 930-940
Open Access | Times Cited: 1
The Interactions between Cells and Viruses
Masahiro Fujimuro
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6886-6886
Open Access | Times Cited: 1
Broad Adaptability of Coronavirus Adhesion Revealed from the Complementary Surface Affinity of Membrane and Spikes
Aritz B. García‐Arribas, Pablo Ibáñez‐Freire, Diego Carlero, et al.
Advanced Science (2024)
Open Access | Times Cited: 1
SARS-CoV-2 Spike Protein Mutation at Cysteine-488 Impairs Its Golgi Localization and Intracellular S1/S2 Processing
Yuichiro Yamamoto, Tetsuya Inoue, Miyu Inoue, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15834-15834
Open Access | Times Cited: 8
Effects of spike proteins on angiotensin converting enzyme 2 (ACE2)
Jennyfer Bejoy, Charlye I. Williams, Hattie J. Cole, et al.
Archives of Biochemistry and Biophysics (2023) Vol. 748, pp. 109769-109769
Open Access | Times Cited: 4
Direct Inhibition of SARS-CoV-2 Spike Protein by Peracetic Acid
Yuichiro Yamamoto, Yoshio Nakano, Mana Murae, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 20-20
Open Access | Times Cited: 7
Targeting SARS‐CoV‐2 by synthetic dual‐acting thiol compounds that inhibit Spike/ACE2 interaction and viral protein production
Alessandra Fraternale, Marta De Angelis, Riccardo De Santis, et al.
The FASEB Journal (2022) Vol. 37, Iss. 2
Open Access | Times Cited: 7
Characterization and Utilization of Disulfide-Bonded SARS-CoV-2 Receptor Binding Domain of Spike Protein Synthesized by Wheat Germ Cell-Free Production System
Yutaro Yamaoka, Sundararaj Stanleyraj Jeremiah, Rikako Funabashi, et al.
Viruses (2022) Vol. 14, Iss. 7, pp. 1461-1461
Open Access | Times Cited: 6
SARS-Cov-2 Spike Protein Mutation at Cysteine-488 Impairs Its Golgi Localization And Intracellular S1/S2 Processing
Yuichiro Yamamoto, Tetsuya Inoue, Mana Murae, et al.
(2022)
Open Access | Times Cited: 5
Development of spray-dried N-acetylcysteine dry powder for inhalation
Lorenzo Mancini, Marco Paolantoni, Aurélie Schoubben, et al.
International Journal of Pharmaceutics (2022) Vol. 631, pp. 122550-122550
Closed Access | Times Cited: 5
Omicron Spike Protein Is Vulnerable to Reduction
Zhong Yao, Betty Geng, Edyta Marcon, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Inhibition of the Cell Uptake of Delta and Omicron SARS-CoV-2 Pseudoviruses by N-Acetylcysteine Irrespective of the Oxidoreductive Environment
Sebastiano La Maestra, Silvano Garibaldi, Roumen Balansky, et al.
Cells (2022) Vol. 11, Iss. 20, pp. 3313-3313
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top